Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 28770-01-6 | MDL No. : | MFCD18818644 |
Formula : | C8H17NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DZARITHRMKPIQB-UHFFFAOYSA-N |
M.W : | 159.23 | Pubchem ID : | 120043 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 47.51 |
TPSA : | 32.7 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.77 cm/s |
Log Po/w (iLOGP) : | 2.25 |
Log Po/w (XLOGP3) : | 0.7 |
Log Po/w (WLOGP) : | -0.09 |
Log Po/w (MLOGP) : | 0.43 |
Log Po/w (SILICOS-IT) : | 0.72 |
Consensus Log Po/w : | 0.8 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.07 |
Solubility : | 13.5 mg/ml ; 0.0851 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.96 |
Solubility : | 17.3 mg/ml ; 0.109 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.6 |
Solubility : | 39.8 mg/ml ; 0.25 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.79 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 108149-63-9 ]
(R)-tert-Butyl 4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate
Similarity: 0.59
[ 108149-65-1 ]
(S)-tert-Butyl 4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate
Similarity: 0.59
[ 1174020-52-0 ]
tert-Butyl 2-(hydroxymethyl)-1,4-oxazepane-4-carboxylate
Similarity: 0.58
[ 135065-69-9 ]
4-Boc-2-Hydroxymethylmorpholine
Similarity: 0.55
[ 135065-76-8 ]
(S)-tert-Butyl 2-(hydroxymethyl)morpholine-4-carboxylate
Similarity: 0.55
[ 108149-63-9 ]
(R)-tert-Butyl 4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate
Similarity: 0.59
[ 108149-65-1 ]
(S)-tert-Butyl 4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate
Similarity: 0.59
[ 1174020-52-0 ]
tert-Butyl 2-(hydroxymethyl)-1,4-oxazepane-4-carboxylate
Similarity: 0.58
[ 879403-42-6 ]
(S)-tert-Butyl 2-(aminomethyl)morpholine-4-carboxylate
Similarity: 0.57
[ 99208-71-6 ]
(S)-3,3-Dimethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one
Similarity: 0.57
[ 108149-63-9 ]
(R)-tert-Butyl 4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate
Similarity: 0.59
[ 108149-65-1 ]
(S)-tert-Butyl 4-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate
Similarity: 0.59
[ 169206-55-7 ]
tert-Butyl 2-oxo-1-oxa-3,8-diazaspiro[4.5]decane-8-carboxylate
Similarity: 0.54
[ 95715-87-0 ]
(R)-tert-Butyl 4-formyl-2,2-dimethyloxazolidine-3-carboxylate
Similarity: 0.54
[ 102308-32-7 ]
(S)-3-Boc-2,2-dimethyloxazolidine-4-carboxaldehyde
Similarity: 0.54